2nd World congress on

Diabetes & Metabolism

Scientific Program

Keynote Session:

Meetings International - Conference Keynote Speaker Dr Alrefaie Asmaa photo

Dr Alrefaie Asmaa

Department of family medicine, MNGH –KAMC, Jeddah, Saudi Arabia

Title: 12F /12S mnemonic for healthy food that needed for counseling all chronic diseases and even for health maintenance. (Either sick or healthy, young or elder, regardless gender)

Biography:

Dr Asmaa is a consultant Family physician in Ministry of NGHA (KAMC-WR).
She is an Assistant professor in King Saud University for health specialist-WR, She is trainer in Saudi commission of health specialist and was a director of Bahrah PHC. She publishes many paper and report many cases in her specialty.

 

Abstract:

A 12 F/ 12 S mnemonic is a tool to help health care provider to remember a large amount of information about healthy diet and healthy behaviors  
What is a healthy diet?” Many clinicians find themselves at a loss to answer this common question from patients. The difficulty of offering a simple answer is understandable; for that it is important to weave simple and compelling recommendation about healthy diet.
Just remember 10 F (5F yes and 5F NO) + Fitness & Fasting all clients visiting our clinics should be advised to increase their intake of Fluids , Fibers , Fruits & vegetables , Fish , healthy Fat (5F yes) and to avoid Fried food , Fast food , Factory food , unhealthy Fat , Fad added sugar (5F No) details for each will be conducted in the lecture . (Sleep Hygiene, Stress management, Smoking cessation, Self-Monitoring, Social support , Structure Meal , Structure cognition, Slow eating, Setting goal, Success re-enforcement,  Solving problem, Stimuli modifying)  
Meetings International - Conference Keynote Speaker Dr Debmalya Sanyal photo

Dr Debmalya Sanyal

MBBS(Honours), DTM&H, MD(Medicine), MRCP, FRCP, D.M.(Endocrinology), Specialty Certificate in Endocrinology & Diabetes (SCE, UK) , FACE (USA)

Title: Long-term efficacy and safety of anti-hyperglycaemic agents in newonset diabetes after transplant: Results from outpatient-based 1-year follow-up and a brief review of treatment options

Biography:

Professor, Department of Endocrinology,                      

KPC Medical College, Jadavpur, Kolkata

Conjoint Professor, School of Medicine & Public Health,

University of Newcastle, Australia

 Visiting Senior Consultant Endocrinologist,

 NH-RTIICS, GD Diabetes Institute, AMRI, Kolkata

 

Abstract:

Background and aims: Evaluation of long-term efficacy and safety of various anti-hyperglycaemic agents (AHA) for glycaemic control in NODAT, in stable kidney transplant recipients (KTRs) during 1-yearoutpatient follow-up.

Methods: We collected FPG, PPG, HbA1c, serum creatinine, eGFR, blood tacrolimus level, hypoglycaemiaand body weight values from an existing database of KTRs diagnosed to have NODAT. Those newly initiated on AHA over 3 months post-transplant; received standard triple immunosuppressive therapy; and followed up for 1-year after referral, were included.

Results: In ninety-five patients’ (Male ¼ 65), mean decrease at 1-year from baseline in FPG (185.01 ± 62.11 mg/dL), PPG (293.21 ± 85.23 mg/dL) and HbA1c (8.48 ± 1.08%) was 67.09, 126.11 and 1.4 respectively (p < 0.0001). At 1-year, mean HbA1c was 7.08 ± 0.38%, ninety-one patients achieving HbA1c 7.5%. Fifty-two patients received oral combination therapy based on linagliptin/metformin/ repaglinide/gliclazide, 19 received insulin-based regimen, and 24 received linagliptin monotharapey. Thirty patients reported hypoglycaemia (10 with gliclazide and 15 with insulin) and fifty patients gainedbody-weight at 1-year. Mean serum creatinine and eGFR significantly improved by 0.29 and 15.77 from baseline of 1.56 ± 0.62 mg/dL and 53.95 ± 16.10 mL/min/1.73 m2 respectively.

Conclusions: Significant proportion of NODAT patients achieved long-term glycemic control with improved renal function. Combination therapy was needed in most within 1-year. Linagliptin monotherapywas effective, without producing hypoglycaemia or weight gain.